Beta-hydroxybutyrate (3-OHB) can influence the energetic phenotype of breast cancer cells, but does not impact their proliferation and the response to chemotherapy or radiation | Cancer & Metabolism | Full Text

Beta-hydroxybutyrate (3-OHB) can influence the energetic phenotype of breast cancer cells, but does not impact their proliferation and the response to chemotherapy or radiation | Cancer & Metabolism | Full Text

2019 Article Collection: Breast Cancer and Metabolism

The biology of tumor cells in breast cancer is complex and relatively unexplored. Cancer & Metabolism is excited to present the following article highlights that identify novel biomarkers and metabolic profiles of different breast cancer subtypes.

- Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities

- Metabolomics of oncogene-specific metabolic reprogramming during breast cancer

- Beta-hydroxybutyrate (3-OHB) can influence the energetic phenotype of breast cancer cells, but does not impact their proliferation and the response to chemotherapy or radiation